Skip to main content


We are working on a new version of this page and we'd like your opinion. See an early preview or learn more.

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients

  • Franco Maggiolo1Email authorView ORCID ID profile,
  • Roberto Gulminetti2,
  • Layla Pagnucco2,
  • Margherita Digaetano3,
  • Simone Benatti1,
  • Daniela Valenti1,
  • Annapaola Callegaro4,
  • Diego Ripamonti1 and
  • Cristina Mussini3
BMC Infectious DiseasesBMC series – open, inclusive and trusted201717:215

Received: 3 February 2017

Accepted: 8 March 2017

Published: 16 March 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
3 Feb 2017 Submitted Original manuscript
14 Feb 2017 Reviewed Reviewer Report - Laura Waters
22 Feb 2017 Reviewed Reviewer Report - Jose Arribas
6 Mar 2017 Author responded Author comments - Franco Maggiolo
Resubmission - Version 2
6 Mar 2017 Submitted Manuscript version 2
8 Mar 2017 Editorially accepted
16 Mar 2017 Article published 10.1186/s12879-017-2311-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

Division of Infectious Diseases, ASST Papa Giovanni XXIII
Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo
Division of Infectious Diseases, University of Modena
Microbiology and Virology Laboratory, ASST Papa Giovanni XXIII